Your session is about to expire
← Back to Search
IV SafeLock Device Functionality in Emergency Department
N/A
Waitlist Available
Led By Kara Bragg, APRN, DNP
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the IV SafeLock, a device that secures IV lines, in emergency department patients to ensure the lines stay in place and don't get accidentally disconnected.
Eligible Conditions
- Intravenous Access
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Functionality of the IV SafeLock
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Emergency Department NursesExperimental Treatment1 Intervention
Registered nurses will use the IV SafeLock Device on patients during care in the emergency department.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IV SafeLock
2023
N/A
~20
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,061,003 Total Patients Enrolled
1 Trials studying Intravenous Access
169 Patients Enrolled for Intravenous Access
Kara Bragg, APRN, DNPPrincipal InvestigatorMayo Clinic